Shanghai Hutchison Pharmaceuticals Limited
Shanghai Hutchison Pharmaceuticals Limited, often referred to as SHPL, is a prominent player in the pharmaceutical industry, headquartered in Shanghai, China. Established in 1995, the company has made significant strides in the development and manufacturing of innovative healthcare solutions, focusing primarily on prescription medications and over-the-counter products. With a strong presence in both domestic and international markets, SHPL is dedicated to advancing therapeutic areas such as oncology, cardiology, and infectious diseases. The company is recognised for its commitment to quality and research, boasting a robust portfolio of unique formulations that cater to diverse patient needs. Notable achievements include strategic partnerships and a growing market share, positioning Shanghai Hutchison Pharmaceuticals as a leader in the competitive pharmaceutical landscape. Through its dedication to innovation and excellence, SHPL continues to enhance healthcare outcomes globally.
DitchCarbon Score
How does Shanghai Hutchison Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai Hutchison Pharmaceuticals Limited's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shanghai Hutchison Pharmaceuticals Limited's reported carbon emissions
Shanghai Hutchison Pharmaceuticals Limited, headquartered in CN, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in industry-standard practices aimed at reducing environmental impact, although specific initiatives or pledges have not been disclosed. As the pharmaceutical sector increasingly focuses on sustainability, it is essential for companies like Shanghai Hutchison Pharmaceuticals to establish clear climate commitments and measurable targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shanghai Hutchison Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
